Nanjing Red Sun Pharmaceutical Research Institute Co., Ltd. is a wholly-owned subsidiary of Jiangsu Zhongbang. It provides an “One Stop Shop” experience and supports everything from drug discovery research to commercial scale.

Red Sun Institute has grown rapidly depending on three advantages:

1 Region (Yangtze River Delta region is the traditional advantage gathering area of China"s pharmaceutical industry); 

2 Industry (Red Sun Group’s whole industry chain, reliable distribution and sales system); 

3 School-enterprise Cooperation (support from universities, colleges and institutes in the Yangtze River Delta region);

Red Sun Institute aims to build a leading domestic pharmaceutical and medical health platform to better serve the Chinese pharmaceutical industry.